EUVIMEDEUVIMED entdecken
Crossref

Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae

Shiyi Shi, Mengxin Xu, Yining Zhao, Luozhu Feng, Qi Liu, Zhuocheng Yao, Yao Sun, Tieli Zhou iD, Jianzhong Ye iD

ACS Infectious Diseases · 2023

DOI: 10.1021/acsinfecdis.3c00186 ↗

Kurz gefasst

Fachartikel in der Zeitschrift ACS Infectious Diseases, 2023. Verfasst von Shiyi Shi und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Laboratory Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, People's Republ…. Hauptthemen laut MEDLINE: Tigecycline, Klebsiella pneumoniae, Rifampin, Anti-Bacterial Agents. Die Arbeit wurde bisher 8-mal zitiert (Crossref) und nennt 53 Literaturangaben. Gefördert von: National Natural Science Foundation of China, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

TigecyclineKlebsiella pneumoniaeRifampinAnti-Bacterial AgentsKlebsiella InfectionsCarbapenem-Resistant EnterobacteriaceaeAnimalsMicrobial Sensitivity TestsDrug SynergismCarbapenemsMothsDrug Resistance, BacterialMutationBacterial Proteins

Stichwörter der Autor:innen

carbapenem-resistant Klebsiella pneumoniaemutant prevention concentrationsynergistic effecttigecycline

Substanzen

TigecyclineRifampinAnti-Bacterial AgentsCarbapenemsBacterial Proteins

Autor:innen und Institutionen

  • Department of Medical Laboratory Science, School of Laboratory Medicine and Life Science, Wenzhou Medical University, Wenzhou 325035, People's Republic of China.
  • Department of Clinical Laboratory, The First Affiliated Hospital of Wenzhou Medical University, Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province, Wenzhou 325000, People's R…

ORCID-Profile: Tieli Zhou, Jianzhong Ye

Förderung

  • National Natural Science Foundation of China
  • Key Laboratory of Clinical Laboratory Diagnosis and Translational Research of Zhejiang Province

Zitieren

APA

Shi, S., Xu, M., Zhao, Y., Feng, L., Liu, Q., Yao, Z., Sun, Y., Zhou, T., & Ye, J. (2023). Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae. ACS Infectious Diseases. https://doi.org/10.1021/acsinfecdis.3c00186

Vancouver

Shi S, Xu M, Zhao Y, Feng L, Liu Q, Yao Z, et al. Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae. ACS Infectious Diseases. 2023. doi:10.1021/acsinfecdis.3c00186

BibTeX
@article{Shi2023,
  author = {Shi, Shiyi and Xu, Mengxin and Zhao, Yining and Feng, Luozhu and Liu, Qi and Yao, Zhuocheng and Sun, Yao and Zhou, Tieli and Ye, Jianzhong},
  title = {Tigecycline–Rifampicin Restrains Resistance Development in Carbapenem-Resistant Klebsiella pneumoniae},
  journal = {ACS Infectious Diseases},
  year = {2023},
  doi = {10.1021/acsinfecdis.3c00186}
}
Kostenlos starten →